iMORFOSE SPRL
iMORFOSE reported total assets of 60,501 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Feb 2026).
The score of iMORFOSE shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -7 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
iMORFOSE's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −18,099 € | ||||
| Equity | −37,058 € | ||||
| Cash | 37,946 € | ||||
| EBITDA | −13,297 € | ||||
| Total assets | 60,501 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 02 Feb 2026
- Year ended 30 Jun 2024filed on 27 Dec 2024
- Year ended 30 Jun 2023filed on 22 Jan 2024
- Year ended 30 Jun 2022filed on 08 Feb 2023
- Year ended 30 Jun 2021filed on 31 Jan 2022
iMORFOSE's financial analysis
- Solvency-61.3%sector median: 35.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of iMORFOSE
iMORFOSE's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0469.748.234
- VAT number
- BE0469748234
- Peppol
- Registered · 0208:0469748234 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 14 Jan 2000
- Registered office
- 2930 Brasschaat
- Latest accounts
- 2025 · filed on 02 Feb 2026
- Activity
- Valuation and appraisal of real estate on a fee or contract basis (NACE 68322)
iMORFOSE (SPRL) has been based in Brasschaat since 2000, active in: valuation and appraisal of real estate on a fee or contract basis. For 2025, it reports a net loss of 18,099 € and equity of −37,058 €; its revenue is not published. Its solvency stands at -61.3%, below the median of its sector (35.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to iMORFOSE
Companies in the same business, of comparable size and area, outside its group.
- Bureau J Lefebvre & Cie Other real estate activities on a fee or contract basis Sambreville · balance sheet 42,667 €
- Alansart Other real estate activities on a fee or contract basis Grez-Doiceau · balance sheet 86,111 €
- EXPERT-HOME Belgique Other real estate activities on a fee or contract basis Awans · balance sheet 61,739 €
- Estimmotion Other real estate activities on a fee or contract basis Bastogne · balance sheet 57,160 €
- CDC Expertise Other real estate activities on a fee or contract basis Grez-Doiceau · balance sheet 65,934 €
- ICARE - Gestion locative Other real estate activities on a fee or contract basis Liège · balance sheet 68,199 €
- Estimm Other real estate activities on a fee or contract basis Bierbeek · balance sheet 47,437 €
- Prime Invest Other real estate activities on a fee or contract basis Brussels · balance sheet 86,270 €
Frequently asked questions about iMORFOSE
What is the revenue of iMORFOSE?
iMORFOSE files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of iMORFOSE?
In Belgium, the VAT number is the company number prefixed with BE: BE0469748234 for iMORFOSE, if the company is VAT-registered. Its company number (CBE) is 0469.748.234.
Where is the registered office of iMORFOSE?
According to the CBE register, the registered office of iMORFOSE is in 2930 Brasschaat.
What is the equity of iMORFOSE?
At the close of the 2025 financial year, the equity of iMORFOSE amounts to -37,058 €, a solvency of -61.3% of total assets.
Who manages iMORFOSE?
The register lists 1 active mandates at iMORFOSE. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of iMORFOSE
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →